CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
On May 30, 2024, Biogen announced that the European Commission (EC) had granted marketing authorization under exceptional circumstances…
On May 15, 2024, a team of scientists led by National Institutes of Health (NIH) researchers announced it…
Black History Month Celebrates the pioneering accomplishments of James McCune Smith, Rebecca Lee Crumpler, Alexa Canady and Patricia…
Asian American and Pacific Islander History Month celebrates the scientific accomplishments of several firsts, from the first chemo…
On May 1, 2024, the National Institutes of Health’s (NIH) All of Us Research Program announced that it…
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…
On Apr. 24, 2024, surgeons at New York University Langone Health announced they had performed the first combined…
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Mar. 13, 2024, the National Science Board (NSB) published The State of U.S. Science and Engineering 2024,…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
On Feb. 16, 2024, the U.S. Centers for Disease Control and Prevention announced that ten people infected with…
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
On Jan. 5, 2024, the U.S. Food and Drug Administration (FDA) authorized Florida’s Agency for Health Care Administration’s…
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…
On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected…
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
On Aug. 7, 2023, a National Institute of Health supported study found that in 2021, an estimated 2.5…
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
On Mar. 8, 2023, Amphastar Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had granted approval…
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…